Related Experiment Videos
Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma
Tsz-Kwong Man1, Xin-Yan Lu, Kim Jaeweon
1Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA. tcman@txccc.org
BMC Cancer
|August 10, 2004
Summary
This study used array comparative genomic hybridization to identify DNA copy number changes in osteosarcoma, revealing frequent amplifications and deletions. These findings help pinpoint potential diagnostic and therapeutic targets for this bone cancer.
Area of Science:
- Genomics
- Oncology
- Molecular Biology
Background:
- Osteosarcoma is a malignant bone neoplasm in young individuals.
- Characterized by complex karyotypes and frequent chromosomal amplifications.
- Histological response to therapy is the current prognostic standard; improved molecular understanding is needed.
Purpose of the Study:
- To identify DNA copy number changes in osteosarcoma using genome-wide screening.
- To refine understanding of genetic alterations driving osteosarcoma initiation and progression.
- To identify potential diagnostic and therapeutic targets.
Main Methods:
- Genome-wide screening using array comparative genomic hybridization (array-CGH).
- Analysis of DNA copy number changes in 48 osteosarcoma patients.
- Validation of amplified clones using fluorescence in situ hybridization (FISH).
Main Results:
- Copy number gains (79%) were more frequent than losses (66%).
- High-level amplifications occurred in 238 clones (37% recurrent), notably at 1p36.32, 6p21.1, 8q24, 12q14.3, 16p13, and 17p11.2.
- Homozygous deletions were identified in 32 clones, with 7 recurrently deleted regions.
Conclusions:
- Array CGH effectively defines high-resolution DNA copy number changes and amplifications in osteosarcoma.
- The study identified specific amplified and deleted genomic regions.
- These findings suggest potential target genes for future diagnostic and therapeutic strategies.